This website has been developed and funded by Janssen-Cilag Ltd and is intended for UK patients prescribed Stelara® (ustekinumab) only.

Contact us

If you have any questions, comments, or concerns about this privacy policy or the information practices of this site, please contact us as follows:

By post: Janssen-Cilag Ltd, 50–100 Holmers Farm Way, High Wycombe, Buckinghamshire, HP12 4EG.

If you have any questions about your condition, please speak to your doctor or specialist.

Alternatively you could contact NHS Advice Service on 111.

Reporting of side effects

It is important to report adverse events even if it is a known adverse event as this still provides valuable information for monitoring product safety. Please contact the Drug Safety Team on:

Adverse Event Reporting

Tel: 01494 567 447

E-Mail: dsafety@its.jnj.com

Reporting side effects

If you get any side effects, talk to your doctor, pharmacist or nurse. This includes any possible side effects not listed in the package leaflet.
You can also report side effects directly via the Yellow Card Scheme at https://yellowcard.mhra.gov.uk/.
By reporting side effects you can help provide more information on the safety of this medicine.